ID   RCC-KL
AC   CVCL_5881
SY   RCCKL
DR   CLS; 300281
DR   Wikidata; Q54949447
RX   PubMed=28196595;
WW   https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,08:01:01; B*35:01:01,49:01:01; C*04:01:01,07:01:01; DPB1*02:01,19:01; DQA1*01:02:01,01:04:01; DQB1*05:03:01,06:04:01; DRB1*13:02:01,14:01:01 (CLS=300281).
CC   Omics: Protein expression by reverse-phase protein arrays.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300281
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13,14
ST   D16S539: 10,12
ST   D18S51: 17,23
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 22,26
ST   Penta D: 9,12
ST   Penta E: 7,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005;
RA   Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P.,
RA   Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L.,
RA   Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D.,
RA   Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B.,
RA   Liang H.;
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//